Brokerages expect Dyne Therapeutics, Inc. (NYSE:DYN – Get Rating) to post earnings per share (EPS) of ($0.88) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Dyne Therapeutics’ earnings. The lowest EPS estimate is ($1.06) and the highest is ($0.74). Dyne Therapeutics reported earnings per share of ($0.50) during […]
Wall Street brokerages expect that Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) will report earnings of ($0.88) per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Dyne Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.74) and the lowest estimate coming in at ($1.06). Dyne Therapeutics […]
Equities research analysts expect that Dyne Therapeutics, Inc. (NYSE:DYN – Get Rating) will announce earnings per share of ($0.88) for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Dyne Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.74) and the lowest estimate coming in at ($1.06). Dyne Therapeutics reported […]
Shares of Dyne Therapeutics, Inc. (NYSE:DYN – Get Rating) rose 3.6% during mid-day trading on Thursday . The stock traded as high as $9.89 and last traded at $9.89. Approximately 110 shares traded hands during trading, a decline of 100% from the average daily volume of 244,275 shares. The stock had previously closed at $9.55. […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,680,000 shares, a decrease of 28.8% from the February 28th total of 2,360,000 shares. Based on an average daily trading volume, of 235,000 shares, […]